Adjunctive Antidepressant Use and Symptomatic Recovery Among Bipolar Depressed Patients With Concomitant Manic Symptoms: Findings From the STEP-BD
Joseph F. Goldberg(Icahn School of Medicine at Mount Sinai), Michael E. Thase(The University of Texas at San Antonio Health Science Center), S. Nassir Ghaemi(Tufts University), Stephen R. Wisniewski, Roy H. Perlis(Harvard University), David J. Miklowitz, Charles L. Bowden(The University of Texas at San Antonio Health Science Center), Joseph R. Calabrese(University Hospitals of Cleveland)
Cited by 214
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review
|Journal of Affective Disorders|2020|704